Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NAGE

Niagen Bioscience, Inc.

CIK 0001386570 · Nasdaq

NasdaqHealth CareMedicinal Chemicals & Botanical Products
$3.49
↑ 0.12 (3.56%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Options; Risks: Technicals

Key stats

Market Cap
$277.96M
P/E Ratio
14.91
EPS
0.22
Dividend Yield
Not covered
52W Position
3%
Beta
1.29

Valuation multiples

Fwd P/E
13.16
PEG
Not covered
P/B
3.38
P/S
2.13
EV/Revenue
2.13
ROE
22.6%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 3%
$3.17$12.41

Latest Financials

2025-12-31 FY
Revenue
$129.42M
Net Income
$17.38M
Total Assets
$106.41M
Free Cash Flow
–

Recent news